{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:17:06Z","timestamp":1791476226433,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the national natural foundation of China","doi-asserted-by":"crossref","award":["81470939&81770710"],"award-info":[{"award-number":["81470939&81770710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LH14H050002, LY15H050001"],"award-info":[{"award-number":["LH14H050002, LY15H050001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Zhejiang Medical and Health Science and Technology","award":["2016KYB177"],"award-info":[{"award-number":["2016KYB177"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12519-020-00405-w","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T19:05:12Z","timestamp":1622574312000},"page":"242-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review"],"prefix":"10.1007","volume":"17","author":[{"given":"Jiao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-3806","authenticated-orcid":false,"given":"Jian-Hua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"key":"405_CR1","first-page":"724","volume":"42","author":"Nephrology TCSoP","year":"2004","unstructured":"Nephrology TCSoP. Analysis of 1268 patients with chronic renal failure in childhood: a report from 91 hospitals in China from 1990\u20132002. Chin J Pediatr. 2004;42:724\u20139.","journal-title":"Chin J Pediatr"},{"key":"405_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1542\/peds.5.3.486","volume":"5","author":"MG LA Barness","year":"1950","unstructured":"LA Barness MG, Janeway CA. Nephrotic syndrome I. Pediatrics. 1950;5:486\u2013503.","journal-title":"Pediatrics"},{"key":"405_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00431-014-2479-z","volume":"174","author":"D Ribeiro","year":"2015","unstructured":"Ribeiro D, Zawadynski S, Pittet LF, Chevalley T, Girardin E, Parvex P. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome. Eur J Pediatr. 2015;174:911\u20137.","journal-title":"Eur J Pediatr"},{"key":"405_CR4","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","volume":"373","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet. 2009;373:1905\u201317.","journal-title":"Lancet"},{"key":"405_CR5","doi-asserted-by":"publisher","first-page":"e98684","DOI":"10.1371\/journal.pone.0098684","volume":"9","author":"EJ Toonen","year":"2014","unstructured":"Toonen EJ, Laskewitz AJ, van Dijk TH, Bleeker A, Grefhorst A, Schouten AE, et al. Glucose kinetics in the collagen-induced arthritis model: an all-in-one model to assess both efficacy and metabolic side effects of glucocorticoids. PLoS ONE. 2014;9:e98684.","journal-title":"PLoS ONE"},{"key":"405_CR6","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.1038\/s41598-018-25610-6","volume":"8","author":"Y Guo","year":"2018","unstructured":"Guo Y, Wang M, Mou J, Zhao Z, Yang J, Zhu F, et al. Pretreatment of Huaiqihuang extractum protects against cisplatin-induced nephrotoxicity. Sci Rep. 2018;8:7333.","journal-title":"Sci Rep"},{"key":"405_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s00467-011-1808-y","volume":"26","author":"C Zhu","year":"2011","unstructured":"Zhu C, Huang S, Ding G, Yuan Y, Chen Q, Pan X, et al. Protective effects of Huang Qi Huai granules on adriamycin nephrosis in rats. Pediatr Nephrol. 2011;26:905\u201313.","journal-title":"Pediatr Nephrol"},{"key":"405_CR8","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.jfma.2013.10.019","volume":"112","author":"LT Li","year":"2013","unstructured":"Li LT, Shi MY, Wei SY, Li T, Li B. Huai Qi Huang ameliorates proteinuria and hematuria in mild IgA nephropathy patients: a prospective randomized controlled study. J Formos Med Assoc. 2013;112:766\u201372.","journal-title":"J Formos Med Assoc"},{"key":"405_CR9","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.3109\/0886022X.2014.952746","volume":"36","author":"SB Duan","year":"2014","unstructured":"Duan SB, Pan P, Xu Q, Li X, Liu N, Xu J. Preliminary study of Huai Qi Huang granules delay the development of primary glomerular diseases in human. Ren Fail. 2014;36:1407\u201310.","journal-title":"Ren Fail"},{"key":"405_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.17305\/bjbms.2016.887","volume":"16","author":"T Li","year":"2016","unstructured":"Li T, Mao J, Huang L, Fu H, Chen S, Liu A, et al. Huaiqihuang may protect from proteinuria by resisting MPC5 podocyte damage via targeting p-ERK\/CHOP pathway. Bosn J Basic Med Sci. 2016;16:193\u2013200.","journal-title":"Bosn J Basic Med Sci"},{"key":"405_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11655-015-2293-0","volume":"23","author":"H Liu","year":"2017","unstructured":"Liu H, Sun W, Gu LB, Tu Y, Yu BY, Hu H. Huaiqihuang Granules reduce proteinuria by enhancing nephrin expression and regulating necrosis factor kappaB signaling pathway in adriamycin-induced nephropathy. Chin J Integr Med. 2017;23:279\u201387.","journal-title":"Chin J Integr Med"},{"key":"405_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2105\/AJPH.2020.305609","volume":"110","author":"M Nasser","year":"2020","unstructured":"Nasser M. Cochrane handbook for systematic reviews of interventions. Am J Public Health. 2020;110:753\u20134.","journal-title":"Am J Public Health"},{"key":"405_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.evalprogplan.2010.09.004","volume":"34","author":"CLS Coryn","year":"2011","unstructured":"Coryn CLS. Introduction to meta-analysis. Eval Program Plann. 2011;34:160\u20131.","journal-title":"Eval Program Plann"},{"key":"405_CR14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Brit Med J. 2003;327:557\u201360.","journal-title":"Brit Med J"},{"key":"405_CR15","first-page":"29","volume":"14","author":"AB Haidich","year":"2010","unstructured":"Haidich AB. Meta-analysis in medical research. Hippokratia. 2010;14:29\u201337.","journal-title":"Hippokratia"},{"key":"405_CR16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"405_CR17","first-page":"33","volume":"25","author":"B Zhang","year":"2010","unstructured":"Zhang B. Changes of serum cytokines in children with primary nephrotic syndrome before and after treatment with Huaiqihuang granule. Chin J Pract Pediatr. 2010;25:33\u20136.","journal-title":"Chin J Pract Pediatr"},{"key":"405_CR18","first-page":"49","volume":"6","author":"ZY Sha","year":"2016","unstructured":"Sha ZY, Liu WT. Effect of huaiqihuang granules on serum inflammatory cytokines in children with primary nephrotic syndrome. China Med Pharm. 2016;6:49\u201351.","journal-title":"China Med Pharm"},{"key":"405_CR19","first-page":"2375","volume":"45","author":"GL Qian","year":"2014","unstructured":"Qian GL, Zhao L, Liu AM. Observation on efficacy of Huaiqihuang Granule in treatment of nephritic syndrome in children. Chin Tradit Herb Drugs. 2014;45:2375\u20137.","journal-title":"Chin Tradit Herb Drugs"},{"key":"405_CR20","first-page":"163","volume":"39","author":"YG Liu","year":"2017","unstructured":"Liu YG, Cao S, Lin N, Guo YX, Huang YY. A prospective randomized controlled trial of the effects of Huaiqihuang particles combined with glucorticoid on child primary nephritic syndrome and immune function. J Youjiang Med Univ Natl. 2017;39:163\u20137.","journal-title":"J Youjiang Med Univ Natl"},{"key":"405_CR21","first-page":"31","volume":"17","author":"HY Geng","year":"2015","unstructured":"Geng HY, Cao L, Wang W, Chen DK, Chen CY, Chu M. A prospective, randomized, controlled clinical study of Huai Qi Huang granules in treatment of childhood primary nephrotic syndrome. Chin J Contemp Pediatr. 2015;17:31\u20134.","journal-title":"Chin J Contemp Pediatr"},{"key":"405_CR22","first-page":"446","volume":"27","author":"LL Dai","year":"2012","unstructured":"Dai LL, WU YB, WU LY. The immune state and regulatory function of Haiqihuang particle in the patients with primary nephrotic syndrome. Chin J Pract Pediatr. 2012;27:446\u20138.","journal-title":"Chin J Pract Pediatr"},{"key":"405_CR23","first-page":"1870","volume":"32","author":"SP Feng","year":"2011","unstructured":"Feng SP, Xie M, Wang L, Luo W, Zhang W, Qu Y. Clinic research of pediatric primary nephrotic syndrome of treatment of Huaiqihuang puls glucocorticoid. Sichuan Med J. 2011;32:1870\u20132.","journal-title":"Sichuan Med J"},{"key":"405_CR24","first-page":"855","volume":"27","author":"KJ Xia","year":"2015","unstructured":"Xia KJ, Zhang Q, Sun JX, Kang GG. Effects of HuaiQiHuang Granule on immune function in children with nephrotic syndrome. Mod Pract Med. 2015;27:855\u20137.","journal-title":"Mod Pract Med"},{"key":"405_CR25","first-page":"859","volume":"26","author":"GC Zhao","year":"2011","unstructured":"Zhao GC, Yang YC, Wu YB, Zhang B. Changes of T-regulatory cells and interleukin-10 in children with primary Nephrotic syndrome before and after treatment assisted with Huaiqihuang particles. J Appl Clin Pediat. 2011;26:859\u201367.","journal-title":"J Appl Clin Pediat"},{"key":"405_CR26","first-page":"294","volume":"5","author":"LJ Wu","year":"2013","unstructured":"Wu LJ, Liu CH, Cao GH. Effect of Huaiqihuang Granule on the Changes of Serum Interleukin-6 and Tumor Necrosis Factor-alpha in Children with Nephrotic Syndrome. Chin Pediatr Integr Tradit Western Med. 2013;5:294\u20136.","journal-title":"Chin Pediatr Integr Tradit Western Med"},{"key":"405_CR27","first-page":"593","volume":"14","author":"JY Zhao","year":"2013","unstructured":"Zhao JY, Zhao GC, WU YB. Effect of Huaiqihuang on the change of IL-21 and IFN-\u03b3 in children with primary nephrotic syndrome. Chin J Integr Tradit Western Nephrol. 2013;14:593\u20136.","journal-title":"Chin J Integr Tradit Western Nephrol"},{"key":"405_CR28","first-page":"29","volume":"32","author":"XB Tang","year":"2011","unstructured":"Tang XB, Zhao B, Huang GG, Li HY. Effect of Huaiqihuang Granule on immune function in children with primary nephrotic syndrome. Med Pharm Yunnan. 2011;32:29.","journal-title":"Med Pharm Yunnan"},{"key":"405_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12519-009-0025-2","volume":"5","author":"RR Roy","year":"2009","unstructured":"Roy RR, Roy E, Rahman MH, Hossain MM. Serum immunoglobulin G, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome. World J Pediatr. 2009;5:127\u201331.","journal-title":"World J Pediatr"},{"key":"405_CR30","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","volume":"39","author":"G Lama","year":"2002","unstructured":"Lama G, Luongo I, Tirino G, Borriello A, Carangio C, Salsano ME. T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis. 2002;39:958\u201365.","journal-title":"Am J Kidney Dis"},{"key":"405_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00011-013-0672-6","volume":"63","author":"WD Pereira","year":"2014","unstructured":"Pereira WD, Brito-Melo GEA, Guimaraes FTL, Carvalho TGR, Mateo EC, Silva ACSE. The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies. Inflamm Res. 2014;63:1\u201312.","journal-title":"Inflamm Res"},{"key":"405_CR32","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","volume":"24","author":"C Araya","year":"2009","unstructured":"Araya C, Diaz L, Wasserfall C, Atkinson M, Mu W, Johnson R, et al. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatric Nephrology. 2009;24:1691\u20138.","journal-title":"Pediatric Nephrology"},{"key":"405_CR33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1046\/j.1523-1755.2001.059003975.x","volume":"59","author":"YP Wang","year":"2001","unstructured":"Wang YP, Wang Y, Feng XM, Bag S, Yi S, Kairaitis L, et al. Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy. Kidney Int. 2001;59:975\u201384.","journal-title":"Kidney Int"},{"key":"405_CR34","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molimm.2019.07.001","volume":"114","author":"Y Xia","year":"2019","unstructured":"Xia Y, Xiao T, Ting L, Chang M, Xue Y, Mo W, et al. Circulating follicular T helper cells are possibly associated with low levels of serum immunoglobulin G due to impaired immunoglobulin class-switch recombination of B cells in children with primary nephrotic syndrome. Mol Immunol. 2019;114:162\u201370.","journal-title":"Mol Immunol"},{"key":"405_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1440-1797.2012.01650.x","volume":"17","author":"CC Wei","year":"2012","unstructured":"Wei CC, Yu IW, Lin HW, Tsai AC. Occurrence of infection among children with nephrotic syndrome during hospitalizations. Nephrology. 2012;17:681\u20138.","journal-title":"Nephrology"},{"key":"405_CR36","first-page":"1842","volume":"31","author":"E Soeiro","year":"2016","unstructured":"Soeiro E, Sahade CAR, Pereira BJ, Dalboni MA, Nussenzveig PR, Pilan F, et al. Clinical profile of thromboembolic complications in children and adolescents with nephrotic syndrome. Pediat Nephrol. 2016;31:1842\u20133.","journal-title":"Pediat Nephrol"},{"key":"405_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jiph.2018.09.006","volume":"12","author":"K Alfakeekh","year":"2018","unstructured":"Alfakeekh K, Azar M, Sowailmi BA, Alsulaiman S, Makdob SA, Omair A, et al. Immunosuppressive burden and risk factors of infection in primary childhood nephrotic syndrome. J Infect Public Health. 2018;12:90\u20134.","journal-title":"J Infect Public Health"},{"key":"405_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","volume":"17","author":"MJ Kemper","year":"2002","unstructured":"Kemper MJ, Altrogge H, Ganschow R, Muller-Wiefel DE. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol. 2002;17:413\u20137.","journal-title":"Pediatr Nephrol"},{"key":"405_CR39","first-page":"759","volume":"19","author":"J Liu","year":"2017","unstructured":"Liu J, Yan H, Chen XG, Mu YP. Effects of Huaiqihuang granules on immune function in children with severe Mycoplasma pneumoniae pneumonia. Zhongguo Dang Dai Er Ke Za Zhi. 2017;19:759\u201362.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"405_CR40","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/ptr.5380","volume":"29","author":"AU Khan","year":"2015","unstructured":"Khan AU, Gilani AH. Natural products useful in respiratory disorders: focus on side-effect neutralizing combinations. Phytother Res. 2015;29:1265\u201385.","journal-title":"Phytother Res"},{"key":"405_CR41","first-page":"435","volume":"7","author":"KJ Zheng","year":"2015","unstructured":"Zheng KJ. Impacts of Huaiqihuang granules on immunity function in children with primary nephritic syndrome. Chin Pediatr Integr Tradit Western Med. 2015;7:435\u20137.","journal-title":"Chin Pediatr Integr Tradit Western Med"},{"key":"405_CR42","first-page":"87","volume":"8","author":"CH Wang","year":"2011","unstructured":"Wang CH, Liu P. Clinical study of Huaiqihuang granule regulating immune function in children with nephrotic syndrome. World Health Dig Med Period. 2011;8:87\u20138.","journal-title":"World Health Dig Med Period"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-020-00405-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-020-00405-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-020-00405-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T10:17:30Z","timestamp":1675419450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-020-00405-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1007\/s12519-020-00405-w","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not required for this meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}